Andrea Schneider1,2, Scott Summers3, Flora Tassone4, Andreea Seritan5, David Hessl1,3, Paul Hagerman4, Randi Hagerman1,2. 1. Medical Investigation of Neurodevelopmental Disorders Institute Sacramento California USA. 2. Department of Pediatrics, School of Medicine University of California-Davis, Medical Center Sacramento California USA. 3. Department of Psychiatry and Behavioral Sciences University of California-Davis, Medical Center Sacramento California USA. 4. Department of Biochemistry University of California-Davis, Medical Center Sacramento California USA. 5. Department of Psychiatry, UCSF Weill Institute for Neurosciences University of California San Francisco California USA.
Abstract
BACKGROUND: Fragile X-associated tremor and ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder linked to the FMR1 premutation. OBJECTIVES: FXTAS in women is far less common than in men, and this study represents the largest sample reported to date. METHODS: A total of 53 female premutation carriers with FXTAS (meanage, 66.83 years; FXTAS stages 2-5) and 55 age-matched and demographic background-matched control participants (meanage, 61.94 years) underwent a comprehensive molecular, physiological, neuropsychological, and psychiatric assessment. RESULTS: The large sample of female premutation carriers showed a wide range of variability of clinical signs and symptom progression. The imaging results showed a middle cerebellar peduncles sign in only 6 patients; another symptom included high-signal intensity in the splenium of the corpus callosum, and diffuse cerebral deep white matter changes (e.g., in the pons) are more common. The rate of psychiatric disorders, especially depression, is higher than in the general population. There is a clear impairment in executive functioning and fine motor skills in connection with a higher FXTAS stage. CONCLUSIONS: The manifestation of FXTAS symptoms in female carriers can be diverse with a milder phenotype and a lower penetrance than those observed in male premutation carriers. The middle cerebellar peduncles sign is present in only a small percentage of the sample, and we propose that the imaging criteria for FXTAS in women need to be expanded.
BACKGROUND: Fragile X-associated tremor and ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder linked to the FMR1 premutation. OBJECTIVES: FXTAS in women is far less common than in men, and this study represents the largest sample reported to date. METHODS: A total of 53 female premutation carriers with FXTAS (meanage, 66.83 years; FXTAS stages 2-5) and 55 age-matched and demographic background-matched control participants (meanage, 61.94 years) underwent a comprehensive molecular, physiological, neuropsychological, and psychiatric assessment. RESULTS: The large sample of female premutation carriers showed a wide range of variability of clinical signs and symptom progression. The imaging results showed a middle cerebellar peduncles sign in only 6 patients; another symptom included high-signal intensity in the splenium of the corpus callosum, and diffuse cerebral deep white matter changes (e.g., in the pons) are more common. The rate of psychiatric disorders, especially depression, is higher than in the general population. There is a clear impairment in executive functioning and fine motor skills in connection with a higher FXTAS stage. CONCLUSIONS: The manifestation of FXTAS symptoms in female carriers can be diverse with a milder phenotype and a lower penetrance than those observed in male premutation carriers. The middle cerebellar peduncles sign is present in only a small percentage of the sample, and we propose that the imaging criteria for FXTAS in women need to be expanded.
Authors: S Cohen; K Masyn; J Adams; D Hessl; S Rivera; F Tassone; J Brunberg; C DeCarli; L Zhang; J Cogswell; D Loesch; M Leehey; J Grigsby; P J Hagerman; R Hagerman Journal: Neurology Date: 2006-10-24 Impact factor: 9.910
Authors: L Rodriguez-Revenga; J Pagonabarraga; B Gómez-Anson; O López-Mourelo; I Madrigal; M Xunclà; J Kulisevsky; M Milà Journal: Neurology Date: 2010-10-12 Impact factor: 9.910
Authors: Flora Tassone; John Adams; Elizabeth M Berry-Kravis; Susannah S Cohen; Alfredo Brusco; Maureen A Leehey; Lexin Li; Randi J Hagerman; Paul J Hagerman Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2007-06-05 Impact factor: 3.568
Authors: Victoria Ros-Castelló; Anna Latorre; Juan Álvarez-Linera; Juan C Martinez-Castrillo; Kailash P Bhatia; Isabel Pareés Journal: Mov Disord Clin Pract Date: 2021-05-22